COM:SINGULARGENOMICS

Singular Genomics

Stock

Last Close

21.90

21/11 21:00

Market Cap

19.05M

Beta: -

Volume Today

6.96K

Avg: -

Overview Analysis Metrics Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-12.32M -	-27.95M 126.75%	-98.77M 253.45%	-90.88M 7.99%	-94.82M 4.34%
depreciation and amortization	350K -	639K 82.57%	1.13M 77.31%	6.03M 432.39%	7.22M 19.74%
deferred income tax		281K -	4.14M 1,372.95%		782K -
stock based compensation	170K -	1.06M 523.53%	9.23M 770.85%	13.67M 48.08%	11.40M 16.57%
change in working capital	415K -	858K 106.75%	-2.91M 439.28%	-16.82M 477.71%	-2.25M 86.65%
accounts receivables				-913K -	348K 138.12%
inventory				-13.49M -	-3.54M 73.77%
accounts payables	244K -	-148K 160.66%	1.85M 1,352.70%	-1.17M 163.00%	267K 122.86%
other working capital	171K -	1.01M 488.30%	-4.76M 573.66%	-1.25M 73.79%	2.92M 333.95%
other non cash items	-10K -	234K 2,440%	35.48M 15,061.54%	901K 97.46%	4.01M 344.95%
net cash provided by operating activities	-11.40M -	-24.87M 118.20%	-51.70M 107.86%	-87.09M 68.46%	-73.65M 15.44%
investments in property plant and equipment	-800K -	-1.38M 72.50%	-4.86M 252.46%	-6.02M 23.81%	-970K 83.89%
acquisitions net	30.70M -	-25.39M 182.69%	126.00M 596.34%	33.54M 73.38%
purchases of investments	-42.73M -	-6.08M 85.78%	-195.68M 3,120.08%	-174.71M 10.72%	-183.59M 5.08%
sales maturities of investments	12.03M -	31.46M 161.55%	69.69M 121.50%	141.17M 102.58%	198.37M 40.52%
other investing activites	-30.70M -	25.39M 182.69%	-126.00M 596.34%	-33.54M 73.38%
net cash used for investing activites	-31.50M -	24.00M 176.21%	-130.86M 645.14%	-39.57M 69.76%	13.81M 134.90%
debt repayment	-2.46M -	-7.50M 204.38%	-10.40M 38.67%
common stock issued	41K -	47K 14.63%	240.78M 512,189.36%	171K 99.93%	13K 92.40%
common stock repurchased	-21K -	-30K 42.86%	3.58M 12,023.33%	-450K 112.58%	-19K 95.78%
dividends paid	-2.44M -	-7.50M 207.00%	-3.58M 52.31%
other financing activites	52.19M -	22.50M 56.89%	141.75M 530.06%	1.18M 99.17%	702K 40.51%
net cash used provided by financing activities	47.30M -	7.51M 84.11%	372.13M 4,851.80%	901K 99.76%	696K 22.75%
effect of forex changes on cash
net change in cash	4.41M -	6.65M 50.90%	189.57M 2,751.90%	-125.76M 166.34%	-59.14M 52.97%
cash at beginning of period	1.12M -	5.52M 394.01%	12.17M 120.35%	201.74M 1,557.65%	75.98M 62.34%
cash at end of period	5.52M -	12.17M 120.35%	201.74M 1,557.65%	75.98M 62.34%	16.83M 77.84%
operating cash flow	-11.40M -	-24.87M 118.20%	-51.70M 107.86%	-87.09M 68.46%	-73.65M 15.44%
capital expenditure	-800K -	-1.38M 72.50%	-4.86M 252.46%	-6.02M 23.81%	-970K 83.89%
free cash flow	-12.20M -	-26.25M 115.21%	-56.56M 115.46%	-93.12M 64.62%	-74.62M 19.87%

All numbers in (except ratios and percentages)